Dual blocking of CD47 and PD-L1 increases innate and adaptive immune responses in CTCL. (September 2022) - Han, Z; Feng, M; Wu, X; Su, C; Yuan, Y-C; Qin, H; Zain, J; Akilov, O; Rosen, ST; Querfeld, C